A double-blind crossover trial on the effect of cetylpyridinium chloride 0.05 per cent (Merocet) on plaque accumulation.
D000293:Adolescent; D000328:Adult; D002594:Cetylpyridinium / Q000627:therapeutic use*; D002710:Chlorhexidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003773:Dental Plaque / Q000517:prevention & control*; D004311:Double-Blind Method; D006801:Humans; D009067:Mouthwashes / Q000627:therapeutic use*; D010919:Placebos; D011726:Pyridinium Compounds / Q000627:therapeutic use*
D009067:Mouthwashes; D010919:Placebos; D011726:Pyridinium Compounds; D002594:Cetylpyridinium; D002710:Chlorhexidine